TGFB1 and Hepatitis: In contrast, in an α-GalCer–induced hepatitis mouse model, pharmacological Galectin-3 neutralization could increase the percentage of CD4+CD25+FOXP3+ Treg cells and TGF-β–producing Treg cells among liver-infiltrating cells (22).